Abstract
Selection biases can distort findings from cohort studies. Self-selection into a study cohort can yield results that are not representative of the target population. Screening a population to detect persons with high blood pressure, for example, can lead to misleading estimates of the effects of antihypertensive medication, in the absence of a control group, because subsequent blood pressure measurements will tend to be lower solely by virtue of the selection process. Studying a selected group of workers who were healthy before hiring can obscure the effects of occupational exposures in comparison to a study of the general population. Incomplete follow-up of cohort members can also lead to biased estimates of cumulative risk and relative risk. Some time-related biases can affect cohort studies. Left truncation arises when one only studies subjects who have survived to a certain time; the analysis must take left truncation into account to avoid bias. Prevalent cohorts consist of subjects who have a prevalent disease at the time of enrollment. Because the age at disease onset is often unknown in prevalent cohorts, estimates of cumulative and relative risks are subject to various biases.
References
- 1 Breslow, N. E. & Day, N. E. (1987). Statistical Methods in Cancer Research. Vol. 2: The Design and Analysis of Cohort Studies. International Agency for Research on Cancer, Lyon.
- 2 Breslow, N. E. & Crowley, J. (1974). A large sample study of the life table and product limit estimates under random censorship, Annals of Statistics 2, 437–453.
- 3 Brookmeyer, R. (1987). Time and latency considerations in the quantitative assessment of risk, in Epidemiology and Health Risk Assessment, L. Gordis, ed. Oxford University Press, Oxford, pp. 178–188.
- 4 Brookmeyer, R. & Gail, M. H. (1987). Biases in prevalent cohorts, Biometrics 43, 739–749.
- 5 Brookmeyer, R. & Gail, M. H. (1994). AIDS Epidemiology: A Quantitative Approach. Oxford University Press, Oxford.
- 6 Brookmeyer, R., Gail, M. H. & Polk, B. F. (1987). The prevalent cohort study and the acquired immunodeficiency syndrome, American Journal of Epidemiology 126, 14–24.
- 7 Caldwell, G. G., Kelley, D. B. & Heath, C. W., Jr (1980). Leukemia among participants in military maneuvers at a nuclear bomb test: a preliminary report, Journal of the American Medical Association 244, 1575–1578.
- 8 Cnaan, A. & Ryan, L. (1989). Survival analysis in natural history studies of disease, Statistics in Medicine 8, 1255–1268.
- 9 Cox, D. R. & Oakes, S. D. (1984). Analysis of Survival Data. Chapman & Hall, London.
- 10 Criqui, M. H., Barrett-Connor, E. & Austin, M. (1978). Differences between respondents and nonrespondents in a population based cardiovascular disease study, American Journal of Epidemiology 108, 367–372.
- 11 Criqui, M. H., Austin, M. & Barrett-Connor, E. (1979). The effect of nonresponse on risk ratios in a cardiovascular disease study, Journal of Chronic Diseases 32, 633–638.
- 12 Davis, C. E. (1976). The effect of regression to the mean in epidemiological and clinical studies, American Journal of Epidemiology 104, 493–498.
- 13 Diggle, P. J. & Kenward, M. G. (1994). Informative dropouts in longitudinal data analysis (with discussion), Applied Statistics 43, 49–93.
- 14 Diggle, P. J. et al. (1994). Analysis of Longitudinal Data. Oxford University Press, New York.
- 15
Doll, R. &
Hill, A. B.
(1954).
The mortality of British doctors in relation to their smoking habits. A preliminary report,
British Medical Journal
ii,
1451–1455.
10.1136/bmj.1.4877.1451 Google Scholar
- 16 Ederer, F. (1972). Serum cholesterol: effects of diet and regression toward the mean, Journal of Chronic Disease 25, 277–289.
- 17 Gail, M. H. (1975). A review and critiques of some models in competing risk analysis, Biometrics 35, 209–222.
- 18 Galton, F. (1985). Regression towards mediocrity in hereditary stature, Journal of the Anthropology Institute 15, 246–263.
- 19 Gardner, M. J. & Heady, J. A. (1973). Some effects of within person variability in epidemiological studies, Journal of Chronic Diseases 26, 781–795.
- 20
Gordon, T. F. E.,
Moore, F. E.,
Shurtleff, D. &
Dawber, T. R.
(1959).
Some epidemiologic problems in the long-term study of cardiovascular disease. Observations on the Framingham Study,
Journal of Chronic Diseases
10,
186–206.
10.1016/0021-9681(59)90002-5 Google Scholar
- 21 Greenland, S. (1977). Response and follow-up bias in cohort studies, American Journal of Epidemiology 106, 184–187.
- 22 Heady, J. A. (1973). A cooperative trial in the primary prevention of ischemic heart disease using clofibrate, design methods and progress, Bulletin of the World Health Organization 48, 243–256.
- 23 Hernberg, S. M., Nurminen, M. & Tolonen, N. (1973). Excess mortality from coronary heart disease in viscose rayon workers, Work Environmental Health 10, 93–98.
- 24 Hypertension Detection and Follow-up Program Cooperative Group (1977). Blood pressure studies in 14 communities, Journal of the American Medical Association 237, 2385–2391.
- 25 James, K. E. (1973). Regression toward the mean in uncontrolled clinical studies, Biometrics 29, 121–130.
- 26 Kalbfleisch, J. D. & Lawless, J. F. (1989). Inference based on retrospective ascertainment: an analysis of data on transfusion related AIDS, Journal of the American Statistical Association 84, 360–372.
- 27 Kalbfleisch, J. D. & Prentice, R. L. (1980). The Statistical Analysis of Failure Time Data. Wiley, New York.
- 28 Kelsey, J. L. & Thompson, W. D. (1986). Methods in Observational Epidemiology. Oxford University Press, Oxford.
- 29 Kleinbaum, D. G., Morgenstern, H. & Kupper, L. L. (1981). Selection in epidemiologic studies, American Journal of Epidemiology 113, 452–463.
- 30 Lagakos, S. W. (1979). General right censoring and its impact on the analysis of survival data, Biometrics 35, 139–156.
- 31 Lagakos, S. W., Barraj, L. M. & DeGruttola, V. (1988). Nonparametric analysis of truncated survival data with application to AIDS, Biometrika 75, 515–523.
- 32 Lui, K. -J. Lawrence, D. N., Morgan, W. M., Peterman, T. A., Haverkos, H. W. & Bregman, D. J. (1986). A model based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndrome, Proceedings of the National Academy of Sciences 83, 3051–3055.
- 33 Peterson, A. (1976). Bounds for a joint distribution function with fixed subdistribution functions. Applications to competing risks, Proceedings of the National Academy of Sciences 73, 11–13.
- 34 Robbins, J. M. (1986). A new approach to causal inference in mortality studies with a sustained exposure period-applications to control of the healthy workers effect, Mathematical Modelling 7, 1393–1512.
- 35 Rothman, K. J. (1986). Modern Epidemiology. Little, Brown, & Company, Boston.
- 36 Slud, E. & Byar, D. (1988). How dependent causes of death can make risk factors appear protective, Biometrics 44, 265–269.
- 37 Tsai, W. Y., Jewell, N. P. & Wang, M. C. (1987). A note on the product-limit estimator under right censoring and left truncation, Biometrika 74, 883–886.
- 38 Tsiatis, A. (1975). A nonidentifiability aspect of the problem of competing risks, Proceedings of the National Academy of Sciences 72, 20–22.
- 39 Wang, M. C., Brookmeyer, R. & Jewell, N. P. (1993). Statistical models for prevalent cohort data, Biometrics 49, 1–11.
- 40 Winkelstein, W., Royce, R. A. & Sheppard, H. W. (1990). Median incubation time for human immunodeficiency virus (HIV) (letter), Annals of Internal Medicine 112, 797.
- 41 Wolinsky, S. M., Rinaldo, C. R. & Phair, J. (1990). Response to letter, Annals of Internal Medicine 112, 797–798.
- 42 Wolinksy, S. M., Rinaldo, C. R. & Kwok, S. (1989). Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic Western Blot, Annals of Internal Medicine 111, 961–972.